Ukrainian Pharmaceutical company Farmak is investing over €20M to construct a new plant in Spain. The new facility will be built in the suburbs of Barcelona and will start operating in early 2024, according to the company’s press service. The enterprise, with a complete supply chain, a closed production cycle, and quality control, will produce sterile medicinal products in the form of solutions, suspensions in vials, and syringes. According to the company, the production of medicine will comply with European GMP standards and American FDA standards. In addition to production, Farmak plans to open a multifunctional laboratory complex with an R&D center in Spain.
Farmak invests more than €20M in Spain.
Farmak invests in Spain.